drugset / Trial / NCT01187849
Metformin to Prevent Metabolic Complications in Glucocorticoid Excess
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate if a treatment with metformin compared to placebo reduces metabolic side-effects in patients with glucocorticoid treatment over three months time.
Timeline
- Start
- 2010-08
- Primary completion
- 2015-08
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | — | — |